Alzheimer's Disease: Rethinking Things?
Doubt on Tactic in Alzheimer’s Battle
By GINA KOLATA
The New York Times
Published: August 18, 2010
"The failure of a promising Alzheimer’s drug highlights the gap between diagnosis and treatment."
Read the full article
Labels: Alzheimer, brain, clinical trials, CNS, dementia, neurodegenerative, neuropsychology, neuroscience, pharma, pharmaceutical companies